Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1981 Dec;20(6):718–722. doi: 10.1128/aac.20.6.718

Comparison of vancomycin disposition in rats with normal and abnormal renal functions.

M S Engineer, D H Ho, G P Bodey Sr
PMCID: PMC181788  PMID: 7325638

Abstract

Vancomycin levels in the tissues and urine of rats with renal damage were compared with those of control rats. Renal damage was induced by a single intravenous injection of uranyl nitrate. After 5 days, when the plasma urea nitrogen levels had increased 7- to 22-fold, a single intraperitoneal vancomycin injection of 10 mg/kg yielded significantly higher plasma and tissue levels in these rats than in the control rats that did not receive uranyl nitrate. At 73 h after the vancomycin injection, the plasma vancomycin concentration in the rats with renal damage was 1.8 +/- 1.1 microgram/ml (mean +/- standard deviation), whereas in control rats the level had fallen to 0.004 +/- 0.002 microgram/ml. Control rats excreted 50.5% of a single dose in the urine within the 3 days, whereas rats with renal damage excreted only 35.6%. These results indicate that vancomycin pharmacokinetics is affected by renal function in rats. Therefore, the drug should be used very cautiously in patients with impaired renal function. The serum levels must be monitored, and the frequency and size of doses may have to be reduced.

Full text

PDF
718

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bodey G. P., Rosenbaum B. Effect of prophylactic measures on the microbial flora of patients in protected environment units. Medicine (Baltimore) 1974 May;53(3):209–228. doi: 10.1097/00005792-197405000-00004. [DOI] [PubMed] [Google Scholar]
  2. Cook F. V., Farrar W. E., Jr Vancomycin revisited. Ann Intern Med. 1978 Jun;88(6):813–818. doi: 10.7326/0003-4819-88-6-813. [DOI] [PubMed] [Google Scholar]
  3. Crossley K. B., Rotschafer J. C., Chern M. M., Mead K. E., Zaske D. E. Comparison of a radioimmunoassay and a microbiological assay for measurement of serum vancomycin concentrations. Antimicrob Agents Chemother. 1980 Apr;17(4):654–657. doi: 10.1128/aac.17.4.654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Flamenbaum W., Huddleston M. L., McNeil J. S., Hamburger R. J. Uranyl nitrate-induced acute renal failure in the rat: micropuncture and renal hemodynamic studies. Kidney Int. 1974 Dec;6(6):408–418. doi: 10.1038/ki.1974.126. [DOI] [PubMed] [Google Scholar]
  5. Fong K. L., Ho D. H., Bogerd L., Pan T., Brown N. S., Gentry L., Bodey G. P., Sr Sensitive radioimmunoassay for vancomycin. Antimicrob Agents Chemother. 1981 Jan;19(1):139–143. doi: 10.1128/aac.19.1.139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. GERACI J. E., HEILMAN F. R., NICHOLS D. R., WELLMAN E. W., ROSS G. T. Some laboratory and clinical experiences with a new antibiotic, vancomycin. Antibiot Annu. 1956:90–106. [PubMed] [Google Scholar]
  7. KIRBY W. M., DIVELBISS C. L. Vancomycin; clinical and laboratory studies. Antibiot Annu. 1956:107–117. [PubMed] [Google Scholar]
  8. LEACH W. Ototoxicity of neomycin and other antibiotics. J Laryngol Otol. 1962 Oct;76:774–790. doi: 10.1017/s0022215100060011. [DOI] [PubMed] [Google Scholar]
  9. LEE C. C., ANDERSON R. C., CHEN K. K. Vancomycin, a new antibiotic. V. Distribution, excretion, and renal clearance. Antibiot Annu. 1956:82–89. [PubMed] [Google Scholar]
  10. Lindholm D. D., Murray J. S. Persistence of vancomycin in the blood during renal failure and its treatment by hemodialysis. N Engl J Med. 1966 May 12;274(19):1047–1051. doi: 10.1056/NEJM196605122741902. [DOI] [PubMed] [Google Scholar]
  11. MCCORMICK M. H., MCGUIRE J. M., PITTENGER G. E., PITTENGER R. C., STARK W. M. Vancomycin, a new antibiotic. I. Chemical and biologic properties. Antibiot Annu. 1955;3:606–611. [PubMed] [Google Scholar]
  12. McHenry M. C., Gavan T. L., Gifford R. W., Jr, Geurkink N. A., Van Ommen R. A., Town M. A., Wagner J. G. Gentamicin dosages for renal insufficiency. Adjustments based on endogenous creatinine clearance and serum creatinine concentration. Ann Intern Med. 1971 Feb;74(2):192–197. doi: 10.7326/0003-4819-74-2-192. [DOI] [PubMed] [Google Scholar]
  13. Nechay B. R., Thompson J. D., Saunders J. P. Inhibition by uranyl nitrate of adenosine triphosphatases derived from animal and human tissues. Toxicol Appl Pharmacol. 1980 May;53(3):410–419. doi: 10.1016/0041-008x(80)90354-3. [DOI] [PubMed] [Google Scholar]
  14. Roberts S. M., Levy G. Pharmacokinetic studies of propoxyphene IV: Effect of renal failure on systemic clearance in rats. J Pharm Sci. 1980 Mar;69(3):363–364. doi: 10.1002/jps.2600690335. [DOI] [PubMed] [Google Scholar]
  15. Uhl J. R., Anhalt J. P. High performance liquid chromatographic assay of vancomycin in serum. Ther Drug Monit. 1979;1(1):75–83. doi: 10.1097/00007691-197901000-00008. [DOI] [PubMed] [Google Scholar]
  16. Walker C. A., Kopp B. Sensitive bioassay for vancomycin. Antimicrob Agents Chemother. 1978 Jan;13(1):30–33. doi: 10.1128/aac.13.1.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Yale C. E., Torhorst J. B. Critical bleeding and plasma volumes of the adult germfree rat. Lab Anim Sci. 1972 Aug;22(4):497–502. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES